Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-I in human hepatocellular carcinoma-Reference-Cited by-同舟云学术

Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-I in human hepatocellular carcinoma

Published:2004-10 Issue:10 Volume:19 Page:1121-1127
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

FUJIWARA KEISHI,HIGASHI TOSHIHIRO,NOUSO KAZUHIRO,NAKATSUKASA HARUSHIGE,KOBAYASHI YOSHIYUKI,UEMURA MASAYUKI,NAKAMURA SHIN-ICHIRO,SATO SHUICHIRO,HANAFUSA TADASHI,YUMOTO YASUHIRO,NAITO ICHIRO,SHIRATORI YASUSHI

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2004.03467.x/fullpdf

Reference39 articles.

1. Hepatocellular carcinoma: Recent progress

2. Strategies for the Development of Vaccines to Treat Breast Cancer

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma;Cancer Research;2024-03-15

2. Treatment Options for Hepatocellular Carcinoma Using Immunotherapy: Present and Future;Journal of Clinical and Translational Hepatology;2024-02-28

3. Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies;Cancers;2023-05-05

4. Immunotherapy for hepatocellular carcinoma: Recent advances and future targets;Pharmacology & Therapeutics;2023-04

5. Identification of a Novel Costimulatory Molecule-Related Signature to Predict Prognostic Risk and Immunotherapy Response in Hepatocellular Carcinoma;2023-01-12